Skip to main content
Livermore
Livermore
ZHEN

Fifth Third Bancorp

SEC CIK
0000035527
Latest filing
Aug 5, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
95,681
Value
$7.49M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HALO by Fifth Third Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202695,681$7.49M<0.1%+27,553+40.4%AddedHolders
Q1 202668,128$4.40M<0.1%+66,546+4,206.4%AddedHolders
Q4 20251,582$106.5K<0.1%+84+5.6%AddedHolders
Q3 20251,498$109.9K<0.1%−4,354−74.4%ReducedHolders
Q2 20255,852$304.4K<0.1%−4,165−41.6%ReducedHolders
Q1 202510,017$639.2K<0.1%+2,276+29.4%AddedHolders
Q4 20247,741$370.1K<0.1%−58−0.7%ReducedHolders
Q3 20247,799$446.4K<0.1%−3,407−30.4%ReducedHolders
Q2 202411,206$586.7K<0.1%+261+2.4%AddedHolders
Q1 202410,945$445.2K<0.1%−25−0.2%ReducedHolders
Q4 202310,970$405.5K<0.1%−1,292−10.5%ReducedHolders
Q3 202312,262$468.4K<0.1%+308+2.6%AddedHolders
Q2 202311,954$431.2K<0.1%+1,795+17.7%AddedHolders
Q1 202310,159$388.0K<0.1%−2,726−21.2%ReducedHolders
Q4 202212,885$733.2K<0.1%−1,150−8.2%ReducedHolders
Q3 202214,035$555.0K<0.1%−9−0.1%ReducedHolders
Q2 202214,044$618.0K<0.1%−48−0.3%ReducedHolders
Q1 202214,092$562.0K<0.1%+2,299+19.5%AddedHolders
Q4 202111,793$474.0K<0.1%+534+4.7%AddedHolders
Q3 202111,259$458.0K<0.1%+417+3.8%AddedHolders
Q2 202110,842$492.0K<0.1%+430+4.1%AddedHolders
Q1 202110,412$434.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.